Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells

被引:48
作者
Pilbeam, CC
Fall, PM
Alander, CB
Raisz, LG
机构
[1] Univ. of Connecticut Health Center, Farmington, CT
[2] Div. of Endocrinology and Metabolism, Univ. of Connecticut Health Center, Farmington, CT 06030
关键词
D O I
10.1359/jbmr.1997.12.8.1198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The production of prostaglandins by osteoblasts is an important mechanism for the regulation of bone turnover, Bone cells contain both inducible and constitutive prostaglandin G/H synthase (PGHS-2 and PGHS-1) and these are differentially regulated, Nonsteroidal anti-inflammatory drugs (NSAIDs), which selectively inhibit one of these enzymes, would be useful in assessing their relative roles in bone metabolism, By Northern analysis, only PGHS-2 is expressed by the immortalized rat osteoblastic cell line, Py1a, while only PGHS-1 is expressed by the rat osteosarcoma cell line, ROS 17/2.8. We tested the relative inhibitory potency (IC50) of seven different NSAIDs on these two cell lines, A recently described selective inhibitor of PGHS-2 NS-398, was approximately 30 times more potent in inhibiting PGHS-2 than PGHS-1, and diclofenac was approximately 10 times more potent, Both had IC50's of approximately 3 nM for PGHS-2 in Py1a cells, Indomethacin, flurbiprofen, naproxen, and piroxicam were relatively nonselective,vith IC50's ranging from 30 nM to 1 mu M, while 6-methoxy-2 naphthyl acetic acid, the active metabolite of nabumetone, was inhibitory only at concentrations greater than 1 mu M. These results indicate that the presently available NSAIDs are unlikely to distinguish completely between effects mediated by PGHS-2 or PGHS-1. However, the cell systems employed could provide a model for the analysis of new compounds with greater selective activity.
引用
收藏
页码:1198 / 1203
页数:6
相关论文
共 19 条
[1]   DICLOFENAC SODIUM INHIBITS BONE-RESORPTION IN POSTMENOPAUSAL WOMEN [J].
BELL, NH ;
HOLLIS, BW ;
SHARY, JR ;
EYRE, DR ;
EASTELL, R ;
COLWELL, A ;
RUSSELL, RGG .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (04) :349-353
[2]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[3]   MECHANISM OF SELECTIVE-INHIBITION OF THE INDUCIBLE ISOFORM OF PROSTAGLANDIN G/H SYNTHASE [J].
COPELAND, RA ;
WILLIAMS, JM ;
GIANNARAS, J ;
NURNBERG, S ;
COVINGTON, M ;
PINTO, D ;
PICK, S ;
TRZASKOS, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11202-11206
[4]  
DeWitt D L, 1993, Am J Med, V95, p40S, DOI 10.1016/0002-9343(93)90396-7
[5]  
FALL PM, 1994, J BONE MINER RES, V9, P1935
[6]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[7]   NS-398, A NOVEL NONSTEROIDAL ANTIINFLAMMATORY DRUG WITH POTENT ANALGESIC AND ANTIPYRETIC EFFECTS, WHICH CAUSES MINIMAL STOMACH LESIONS [J].
FUTAKI, N ;
YOSHIKAWA, K ;
HAMASAKA, Y ;
ARAI, I ;
HIGUCHI, S ;
IIZUKA, H ;
OTOMO, S .
GENERAL PHARMACOLOGY, 1993, 24 (01) :105-110
[8]   EXPRESSION AND SELECTIVE-INHIBITION OF THE CONSTITUTIVE AND INDUCIBLE FORMS OF HUMAN CYCLOOXYGENASE [J].
GIERSE, JK ;
HAUSER, SD ;
CREELY, DP ;
KOBOLDT, C ;
RANGWALA, SH ;
ISAKSON, PC ;
SEIBERT, K .
BIOCHEMICAL JOURNAL, 1995, 305 :479-484
[9]  
HARRISON JR, 1994, J BONE MINER RES, V9, P817
[10]   REGULATION OF THE 2 PROSTAGLANDIN G/H SYNTHASES BY PARATHYROID-HORMONE, INTERLEUKIN-1, CORTISOL, AND PROSTAGLANDIN E(2) IN CULTURED NEONATAL MOUSE CALVARIAE [J].
KAWAGUCHI, H ;
RAISZ, LG ;
VOZNESENSKY, OS ;
ALANDER, CB ;
HAKEDA, Y ;
PILBEAM, CC .
ENDOCRINOLOGY, 1994, 135 (03) :1157-1164